Conference Coverage

New Agents for the Treatment of Prostate Cancer

How can 5 new novel agents impact prostate cancer treatment?


 

References

Dr. Guru Sonpavde discusses the progress in treatments for patients with prostate cancer. Listen to the interview to learn about the 5 novel agents for metastatic castration-resistant prostate cancer and how the understanding of the biology of prostate cancer is changing.

Dr. Sonpavde is one of the authors of "A Focus on Metastatic Castration-Resistant Prostate Cancer," which appeared in the Advances in Hematology and Oncology special issue.

Recommended Reading

Follow-up on Hematuria
Federal Practitioner
Can Coffee Help Prevent Endometrial Cancer?
Federal Practitioner
Oral Treatment Prolongs Survival in Ovarian Cancer
Federal Practitioner
Systemic Treatment and Outcomes of Metastatic Pancreatic Cancer
Federal Practitioner
Prostate Cancer Survivorship Care
Federal Practitioner
Improving Treatment Options for Chronic Myelogenous Leukemia
Federal Practitioner
Special Message from AVAHO President Sean Cosgriff
Federal Practitioner
Hospice Care Guidance
Federal Practitioner
Managing Health Care After Cancer
Federal Practitioner
ASCO's Chemotherapy Administration Safety Standards
Federal Practitioner